Vaishali Pharma Limited (VAISHALI.NS) Stock Overview
Explore Vaishali Pharma Limited’s financial performance, market position, analyst ratings, and future outlook.
Vaishali Pharma Limited (VAISHALI.NS)
Key Financials
Key Financials
Market Cap
870.4M
P/E Ratio
23.43
EPS (TTM)
$-2.70
ROE
0.06%
VAISHALI.NS Stock Analysis & Investment Overview (NSE)
Our AI-powered analysis of Vaishali Pharma Limited (NSE: VAISHALI.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Vaishali Pharma Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of VAISHALI.NS on the NSE shows an RSI of 51.01, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.22 for the NSE listing.
Key metrics behind Vaishali Pharma Limited's NSE-traded stock include a P/E ratio of 23.43 and a market capitalization of 870.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of VAISHALI.NS on the NSE.